All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

PURPOSE: Treatment options in patients (pts.) with advanced relapsed and refractory aggressive B-cell lymphoma are limited. Palliative all-oral chemotherapy regimens reduce in-patient visits and contribute to quality of life. The all-oral low-dose chemotherapy regimen TEPIP comprises the conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Fante, Matthias A., Felsenstein, Mona, Mayer, Stephanie, Gerken, Michael, Klinkhammer-Schalke, Monika, Herr, Wolfgang, Vogelhuber, Martin, Reichle, Albrecht, Heudobler, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127443/
https://www.ncbi.nlm.nih.gov/pubmed/35619924
http://dx.doi.org/10.3389/fonc.2022.852987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127443/
https://www.ncbi.nlm.nih.gov/pubmed/35619924
http://dx.doi.org/10.3389/fonc.2022.852987

Ejemplares similares